Home NYT In a trial, Pfizer-BioNTech’s low-dose shot did not provoke an adequate immune response in 2- to 5-year-olds.

In a trial, Pfizer-BioNTech’s low-dose shot did not provoke an adequate immune response in 2- to 5-year-olds.

Unknown 11:11 NYT

By BY APOORVA MANDAVILLI AND REBECCA ROBBINS from NYT World https://ift.tt/3sf8pnX

In a trial, Pfizer-BioNTech’s low-dose shot did not provoke an adequate immune response in 2- to 5-year-olds. Reviewed by Unknown on 11:11 Rating: 5

No comments:

Subscribe to: Post Comments (Atom)